Dimenhydrinate

Chemical formula: C₂₄H₂₈ClN₅O₃  Molecular mass: 469.97 g/mol  PubChem compound: 10660

Therapeutic indications

Dimenhydrinate is indicated for:

Nausea, vertigo

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Dimenhydrinate is indicated for the prevention of the nausea of the traveler, for the lizards, nausea and vomiting accompanying Meniere’s disease, other conditions, as well as labyrinth interventions.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Nausea, vertigo

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Dimenhydrinate is indicated for the prevention of the nausea of the traveler, for the lizards, nausea and vomiting accompanying Meniere’s disease, other conditions, as well as labyrinth interventions.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Dimenhydrinate is contraindicated in the following cases:

Angle-closure glaucoma, gastrointestinal stenosis, urinary outflow obstruction, exacerbation of asthma, porphyria

at least one of
Angle-closure glaucoma
Gastrointestinal stenosis
Urinary outflow obstruction
Exacerbation of asthma
Porphyria

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.